Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30944092 | 0.92 | CNR1 (0.80) | CNR1CNR2 | |
| Otenabant SCHEMBL1622757 | 0.90 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL30944079 | 0.90 | CNR1 (0.77) | CNR1CNR2 | |
| Otenabant SCHEMBL3932007 | 0.90 | CNR1 (0.98) | CNR1CNR2 | |
| SCHEMBL12009758 | 0.89 | CNR1 (0.75) | CNR1CNR2 | |
| SCHEMBL38660277 | 0.87 | CNR1 (0.63) | CNR1CNR2 | |
| SCHEMBL38658962 | 0.85 | CNR1 (0.61) | CNR1CNR2 | |
| SCHEMBL12009752 | 0.85 | CNR1 (0.69) | CNR1CNR2 | |
| SCHEMBL5370899 | 0.84 | CNR1 (0.73) | CNR1CNR2 | |
| SCHEMBL5235768 | 0.84 | CNR1 (0.88) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036731-A | CB1 receptor inverse agonist compound, pharmaceutical composition, preparation method and application thereof | 北京康辰药业股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4608835-A1 | PURINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF | Novo Nordisk A/S (DK) | 2025-09-03 | — | — | EP | disclosed |
| CN-120129684-A | Purine compound, composition containing same and use thereof | 诺和诺德股份有限公司 | 2025-06-10 | — | — | CN | disclosed |